Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease: Consensus Statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces

Cardiac catheterization is important in the diagnosis and risk stratification of pulmonary hypertensive vascular disease (PHVD) in children. Acute vasoreactivity testing provides key information about management, prognosis, therapeutic strategies, and efficacy. Data obtained at cardiac catheterization continue to play an important role in determining the surgical options for children with congenital heart disease and clinical evidence of increased pulmonary vascular resistance. The Pediatric and Congenital Heart Disease Task Forces of the Pulmonary Vascular Research Institute met to develop a consensus statement regarding indications for, conduct of, acute vasoreactivity testing with, and pitfalls and risks of cardiac catheterization in children with PHVD. This document contains the essentials of those discussions to provide a rationale for the hemodynamic assessment by cardiac catheterization of children with PHVD.

[1]  M. Elgendi,et al.  Hyperoxia Reduces Oxygen Consumption in Children with Pulmonary Hypertension , 2014, Pediatric Cardiology.

[2]  C. Thomson,et al.  Pediatric pulmonary hypertension. , 2013, Journal of the American College of Cardiology.

[3]  Yoav Dori,et al.  Predictors of Catastrophic Adverse Outcomes in Children With Pulmonary Hypertension Undergoing Cardiac Catheterization: A Multi-Institutional Analysis From the Pediatric Health Information Systems Database. , 2015, Journal of the American College of Cardiology.

[4]  I. Adatia,et al.  Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease , 2015, Pediatric Cardiology.

[5]  W. Budts,et al.  A different view on predictors of pulmonary hypertension in secundum atrial septal defect. , 2014, International journal of cardiology.

[6]  S. Harikrishnan,et al.  Repair of Congenital Heart Disease with Associated Pulmonary Hypertension in Children: What are the Minimal Investigative Procedures? Consensus Statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI) , 2014, Pulmonary circulation.

[7]  M. Quail,et al.  Real time magnetic resonance assessment of septal curvature accurately tracks acute hemodynamic changes in pediatric pulmonary hypertension , 2014, Journal of Cardiovascular Magnetic Resonance.

[8]  Qi-wen Zhou,et al.  Patients with Congenital Systemic-to-Pulmonary Shunts and Increased Pulmonary Vascular Resistance: What Predicts Postoperative Survival? , 2014, PloS one.

[9]  A. Sabaté Rotés,et al.  Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry. , 2014, American journal of respiratory and critical care medicine.

[10]  M. Walsh,et al.  Measurement of Oxygen Consumption in Children Undergoing Cardiac Catheterization: Comparison Between Mass Spectrometry and the Breath-by-Breath Method , 2014, Pediatric Cardiology.

[11]  Alejandro Torres,et al.  Safety of Cardiac Catheterization at a Center Specializing in the Care of Patients with Pulmonary Arterial Hypertension , 2013, Pulmonary circulation.

[12]  H. Hillege,et al.  Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension. , 2013, International journal of cardiology.

[13]  A. Taylor,et al.  Prognostic Significance of Cardiac Magnetic Resonance Imaging in Children With Pulmonary Hypertension , 2013, Circulation. Cardiovascular imaging.

[14]  J. Feinstein,et al.  Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice , 2013, European Respiratory Journal.

[15]  Yuhui Zhang,et al.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. , 2013, Chest.

[16]  R. Barst,et al.  Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee , 2013, Pulmonary circulation.

[17]  R. Friesen,et al.  Acute Pulmonary Vasodilator Testing With Inhaled Treprostinil in Children With Pulmonary Arterial Hypertension , 2013, Pediatric Cardiology.

[18]  R. Naeije,et al.  The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease , 2012, European Respiratory Journal.

[19]  J. Kreuder,et al.  Assessment of pulmonary endothelial function during invasive testing in children and adolescents with idiopathic pulmonary arterial hypertension. , 2012, Journal of the American College of Cardiology.

[20]  Hong Wang,et al.  Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers. , 2012, The American journal of cardiology.

[21]  Deepak L. Bhatt,et al.  Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension. , 2012, Critical pathways in cardiology.

[22]  R. Barst,et al.  Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management , 2011, Circulation.

[23]  B. McCrindle,et al.  Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. , 2011, American heart journal.

[24]  S. Harikrishnan,et al.  A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011 , 2011, Pulmonary circulation.

[25]  S. Harikrishnan,et al.  Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011 , 2011, Pulmonary circulation.

[26]  J. Hoffman.  Pulmonary Vascular Resistance and Viscosity: The Forgotten Factor , 2011, Pediatric Cardiology.

[27]  D. Ivy,et al.  Assessment of pulmonary hypertension in the pediatric catheterization laboratory: Current insights from the magic registry , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[28]  A. Saxena,et al.  Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension. , 2010, Journal of cardiothoracic and vascular anesthesia.

[29]  L. Sinoway,et al.  Revisiting the role of oxygen therapy in cardiac patients. , 2010, Journal of the American College of Cardiology.

[30]  C. Mélot,et al.  Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy , 2010, Heart.

[31]  A. Bush,et al.  Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit , 2010, American heart journal.

[32]  T. Delhaas,et al.  Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. , 2010, The American journal of cardiology.

[33]  I. Schulze-Neick,et al.  Childhood idiopathic pulmonary arterial hypertension: a national cohort study , 2010, Heart.

[34]  R. Barst,et al.  Vasodilator Testing with Nitric Oxide and/or Oxygen in Pediatric Pulmonary Hypertension , 2010, Pediatric Cardiology.

[35]  A. Ribeiro,et al.  Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide. , 2010, Respiratory medicine.

[36]  M. Almodovar,et al.  Anesthesia considerations for children with pulmonary hypertension. , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[37]  C. Dauphin,et al.  Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. , 2010, Archives of cardiovascular diseases.

[38]  S. Bratton,et al.  Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine , 2010, Paediatric anaesthesia.

[39]  M. Rabinovitch,et al.  Balloon occlusion pulmonary wedge angiography and lung biopsy assessment in the child with a congenital cardiac defect , 2009, Cardiology in the Young.

[40]  S. Yoo,et al.  Aortopulmonary Collaterals After Bidirectional Cavopulmonary Connection or Fontan Completion: Quantification With MRI , 2009, Circulation. Cardiovascular imaging.

[41]  A. Limsuwan,et al.  Aerosolized iloprost for pulmonary vasoreactivity testing in children with long‐standing pulmonary hypertension related to congenital heart disease , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[42]  Jeffrey L. Anderson,et al.  ACCF/AHA Expert Conseusus Document , 2009 .

[43]  N. Sekarski,et al.  Frequency of severe pulmonary hypertension complicating "isolated" atrial septal defect in infancy. , 2008, The American journal of cardiology.

[44]  M. Weiss,et al.  Comparison of Calculated with Measured Oxygen Consumption in Children Undergoing Cardiac Catheterization , 2008, Pediatric Cardiology.

[45]  R. K. Kumar,et al.  Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[46]  J. Feinstein,et al.  Ketamine Does Not Increase Pulmonary Vascular Resistance in Children with Pulmonary Hypertension Undergoing Sevoflurane Anesthesia and Spontaneous Ventilation , 2007, Anesthesia and analgesia.

[47]  A. McEwan,et al.  Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. , 2007, British journal of anaesthesia.

[48]  R. Friesen,et al.  Perioperative Complications in Children with Pulmonary Hypertension Undergoing Noncardiac Surgery or Cardiac Catheterization , 2007, Anesthesia and analgesia.

[49]  B. Lundell,et al.  Oxygen consumption in infants and children during heart catheterization , 1996, Pediatric Cardiology.

[50]  U. Fakler,et al.  Assumed oxygen consumption frequently results in large errors in the determination of cardiac output. , 2005, The Journal of thoracic and cardiovascular surgery.

[51]  M. Humbert,et al.  Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.

[52]  J. Moller,et al.  The pulmonary vascular response to oxygen and its influence on operative results in children with ventricular septal defect , 1982, Pediatric Cardiology.

[53]  F. Van de Werf,et al.  Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. , 2004, European heart journal.

[54]  M. Wimmer,et al.  Long-term hemodynamic effects of nifedipine on congenital heart disease with eisenmenger's mechanism in children , 1992, Cardiovascular Drugs and Therapy.

[55]  D. Webb,et al.  Cardiovascular Effects of Acute Oxygen Administration in Healthy Adults , 2003, Journal of cardiovascular pharmacology.

[56]  A. Redington,et al.  Measured versus estimated oxygen consumption in ventilated patients with congenital heart disease: The validity of predictive equations , 2003, Critical care medicine.

[57]  J. Tharakan,et al.  Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance. , 2003, Indian heart journal.

[58]  W. Hop,et al.  Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease: an indicator for pulmonary vascular disease? , 2002, Chest.

[59]  F. Van de Werf,et al.  Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome , 2001, Heart.

[60]  A. Kalangos,et al.  Inhaled Nitric Oxide Versus Aerosolized Iloprost in Secondary Pulmonary Hypertension in Children With Congenital Heart Disease: Vasodilator Capacity and Cellular Mechanisms , 2001, Circulation.

[61]  J. Wilkinson.  Haemodynamic calculations in the catheter laboratory , 2001, Heart.

[62]  J. Lock,et al.  Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. , 1999, Journal of the American College of Cardiology.

[63]  J. Räsänen,et al.  Measured versus predicted oxygen consumption in children with congenital heart disease , 1998, Heart.

[64]  P. Trindade,et al.  Use of assumed versus measured oxygen consumption for the determination of cardiac output using the Fick principle. , 1998, Catheterization and cardiovascular diagnosis.

[65]  P. Clarkson,et al.  Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. , 1989, The American journal of cardiology.

[66]  B. Corrin,et al.  Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. , 1988, British heart journal.

[67]  D. G. Ritter,et al.  Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. , 1987, Circulation.

[68]  A Bush,et al.  Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease? , 1986, Circulation.

[69]  R. Barst.  Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. , 1986, Chest.

[70]  A. Rocchini,et al.  Cardiovascular effects of breathing 95 percent oxygen in children with congenital heart disease. , 1983, The American journal of cardiology.

[71]  C. Kleinman,et al.  Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. , 1982, The New England journal of medicine.

[72]  J. F. Keane,et al.  Quantitative Analysis of the Pulmonary Wedge Angiogram in Congenital Heart Defects: Correlation with Hemodynamic Data and Morphometric Findings in Lung Biopsy Tissue , 1981, Circulation.

[73]  G. Vlahakes,et al.  The Pathophysiology of Failure in Acute Right Ventricular Hypertension: Hemodynamic and Biochemical Correlations , 1981, Circulation.

[74]  M. Freed,et al.  Oximetric detection of intracardiac left-to-right shunts. , 1979, British heart journal.

[75]  J. F. Keane,et al.  Cardiac output measured by infants and children thermodilution in , 1978 .

[76]  J. F. Keane,et al.  Cardiac output measured by thermodilution in infants and children. , 1978, The Journal of pediatrics.

[77]  D. G. Ritter,et al.  Selection of Patients with Truncus Arteriosus for Surgical Correction: Anatomic and Hemodynamic Considerations , 1974, Circulation.

[78]  H. Swan,et al.  Effect of Breathing Oxygen on Pulmonary Artery Pressure and Pulmonary Vascular Resistance in Patients with Ventricular Septal Defect , 1961, Circulation.